Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chengzhi Li
Institutions:
First Affiliated Hospital of Jinan University,
Chongqing Medical University
Observed institutions:
Hubei University of Medicine,
Jinan University,
University of Jinan,
Third Affiliated Hospital of Sun Yat-sen University,
First Affiliated Hospital of Jinan University,
Chongqing Medical University
show all 6
ORCID:
0000-0002-6661-166X
Observed ORCID:
0000-0002-6661-166X
OpenAlex ID:
A5041618790
A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy
2023
·
Xuelei He
, Kai Li
, et al.
·
La radiologia medica
·
38
PDF
Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis
2024
·
Yangyang Li
, Jiandong Guo
, et al.
·
Hepatology International
·
21
Idarubicin-loaded degradable hydrogel for TACE therapy enhances anti-tumor immunity in hepatocellular carcinoma
2024
·
Xiaokai Zhang
, Xiujiao Deng
, et al.
·
Materials Today Bio
·
16
Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning
2024
·
Wendao Liu
, Ran Wei
, et al.
·
European Radiology
·
16
PDF
Efficiency and safety of hepatic arterial infusion chemotherapy ( HAIC ) combined with anti‐ PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis
2024
·
Yangyang Li
, Wendao Liu
, et al.
·
Cancer Medicine
·
15
PDF
Multiparametric MRI‐based model for prediction of local progression of hepatocellular carcinoma after thermal ablation
2023
·
Chao Chen
, Qiuying Han
, et al.
·
Cancer Medicine
·
15
Efficacy and safety of HAIC alone vs. HAIC combined with lenvatinib for treatment of advanced hepatocellular carcinoma
2023
·
Fang Long
, Shali Chen
, et al.
·
Medical Oncology
·
14
PDF
Elevated triglyceride-glucose index associated with increased risk of diabetes in non-obese young adults: a longitudinal retrospective cohort study from multiple Asian countries
2024
·
Jian Han
, Weifeng Dai
, et al.
·
Frontiers in Endocrinology
·
10
PDF
Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and sequential ablation in the treatment of advanced hepatocellular carcinoma
2022
·
Yulong Liu
, Yansong Qiao
, et al.
·
Cancer Medicine
·
10
PDF
Hepatic arterial infusion chemotherapy and sequential ablation treatment in large hepatocellular carcinoma
2022
·
Huimin You
, Xingyi Liu
, et al.
·
International Journal of Hyperthermia
·
10
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study
2024
·
Chao An
, Ran Wei
, et al.
·
British Journal of Cancer
·
8
PDF
Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization
2025
·
Ran Wei
, Zelong Liu
, et al.
·
Radiology Imaging Cancer
·
6
A SEER data-based nomogram for the prognostic analysis of survival of patients with Kaposi’s sarcoma
2023
·
Wanghai Li
, Ling Wang
, et al.
·
Journal of Cancer Research and Therapeutics
·
3
Refining Intra-Arterial Therapy Selection for Large Hepatocellular Carcinoma: A Deep Learning Approach Based on Covariate Interaction Analysis
2025
·
Chao An
, Lei Li
, et al.
·
Journal of Hepatocellular Carcinoma
·
2
PDF
Drug-eluting bead TACE improves the efficacy of HAIC combined with molecular-targeted therapy and anti-PD-1 immunotherapy in large hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus: a multicenter retrospective cohort study
2026
·
Jiayan Ni
, Hongliang Sun
, et al.
·
BMC Cancer
·
1
Safety and Efficacy of TACE-HAIC Combined with Lenvatinib and PD-1 Inhibitors in Large Intermediate-Stage Hepatocellular Carcinoma: A Multi-Center Retrospective Study
2026
·
Jiayan Ni
, Chengzhi Li
, et al.
·
Journal of Hepatocellular Carcinoma
·
1
PDF
Resection versus microwave ablation following conversion therapy for unresectable hepatocellular carcinoma
2025
·
Hanyu Jiang
, Mengxuan Zuo
, et al.
·
International Journal of Surgery
·
1
Correction: A multitask deep learning radiomics model for predicting the macrotrabecular‑massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy
2024
·
Xuelei He
, Kai Li
, et al.
·
La radiologia medica
·
1
PDF
Cisplatin combined with high-intensity focused ultrasound inhibits endometrial cancer progression by inducing pyroptosis
2026
·
Chuqiang Shu
, Pu Zhang
, et al.
·
International Journal of Hyperthermia
PDF
The value of 18F-FAPI-04 PET/CT in the assessment of unresectable hepatocellular carcinoma after selective internal radiation therapy: a preliminary exploratory study
2026
·
Huanyu Gong
, Yong Cheng
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
Effectiveness and Safety of TRIPLET Protocol in Patients with Intermediate-Stage Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Refractory
2025
·
Yue Zhao
, Yong Wu
, et al.
·
Academic Radiology
PDF
Construction of a Prognostic Nomogram for Major Amputation Within 30 Days Postrevascularization in Patients With Acute Lower Limb Ischemia Based on 2D Perfusion Parameters
2024
·
Jiandong Guo
, Yinsheng Lin
, et al.
·
Journal of Endovascular Therapy
Show more works
View as search
Works count:
22
Citation count:
188
H-index:
10
I10-index:
10
Year
Topic
Type